Global Contract Pharmaceutical Manufacturing Market Analysis and Forecast 2024-2030

Global Contract Pharmaceutical Manufacturing Market Analysis and Forecast 2024-2030


Summary

Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.

According to APO Research, The global Contract Pharmaceutical Manufacturing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Contract Pharmaceutical Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Contract Pharmaceutical Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Contract Pharmaceutical Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Contract Pharmaceutical Manufacturing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Contract Pharmaceutical Manufacturing include Catalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim and Fareva Holding, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes

This report presents an overview of global market for Contract Pharmaceutical Manufacturing, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Contract Pharmaceutical Manufacturing, also provides the revenue of main regions and countries. Of the upcoming market potential for Contract Pharmaceutical Manufacturing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Contract Pharmaceutical Manufacturing revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Contract Pharmaceutical Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Contract Pharmaceutical Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Contract Pharmaceutical Manufacturing segment by Company

Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Contract Pharmaceutical Manufacturing segment by Type

Oral
Injectable
API
Other
Contract Pharmaceutical Manufacturing segment by Application

Large Enterprise
Small Medium Enterprise
Contract Pharmaceutical Manufacturing segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contract Pharmaceutical Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contract Pharmaceutical Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contract Pharmaceutical Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Contract Pharmaceutical Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Contract Pharmaceutical Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Contract Pharmaceutical Manufacturing revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.


1 Market Overview
1.1 Product Definition
1.2 Contract Pharmaceutical Manufacturing Market by Type
1.2.1 Global Contract Pharmaceutical Manufacturing Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Contract Pharmaceutical Manufacturing Market by Application
1.3.1 Global Contract Pharmaceutical Manufacturing Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Large Enterprise
1.3.3 Small Medium Enterprise
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Contract Pharmaceutical Manufacturing Market Dynamics
2.1 Contract Pharmaceutical Manufacturing Industry Trends
2.2 Contract Pharmaceutical Manufacturing Industry Drivers
2.3 Contract Pharmaceutical Manufacturing Industry Opportunities and Challenges
2.4 Contract Pharmaceutical Manufacturing Industry Restraints
3 Global Growth Perspective
3.1 Global Contract Pharmaceutical Manufacturing Market Perspective (2019-2030)
3.2 Global Contract Pharmaceutical Manufacturing Growth Trends by Region
3.2.1 Global Contract Pharmaceutical Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Contract Pharmaceutical Manufacturing Market Size by Region (2019-2024)
3.2.3 Global Contract Pharmaceutical Manufacturing Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Contract Pharmaceutical Manufacturing Revenue by Players
4.1.1 Global Contract Pharmaceutical Manufacturing Revenue by Players (2019-2024)
4.1.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Players (2019-2024)
4.1.3 Global Contract Pharmaceutical Manufacturing Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Contract Pharmaceutical Manufacturing Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Contract Pharmaceutical Manufacturing Key Players Headquarters & Area Served
4.4 Global Contract Pharmaceutical Manufacturing Players, Product Type & Application
4.5 Global Contract Pharmaceutical Manufacturing Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Contract Pharmaceutical Manufacturing Market CR5 and HHI
4.6.2 Global Top 5 and 10 Contract Pharmaceutical Manufacturing Players Market Share by Revenue in 2023
4.6.3 2023 Contract Pharmaceutical Manufacturing Tier 1, Tier 2, and Tier 3
5 Contract Pharmaceutical Manufacturing Market Size by Type
5.1 Global Contract Pharmaceutical Manufacturing Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Contract Pharmaceutical Manufacturing Revenue by Type (2019-2030)
5.3 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Type (2019-2030)
6 Contract Pharmaceutical Manufacturing Market Size by Application
6.1 Global Contract Pharmaceutical Manufacturing Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Contract Pharmaceutical Manufacturing Revenue by Application (2019-2030)
6.3 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Catalent
7.1.1 Catalent Comapny Information
7.1.2 Catalent Business Overview
7.1.3 Catalent Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.1.4 Catalent Contract Pharmaceutical Manufacturing Product Portfolio
7.1.5 Catalent Recent Developments
7.2 DPx
7.2.1 DPx Comapny Information
7.2.2 DPx Business Overview
7.2.3 DPx Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.2.4 DPx Contract Pharmaceutical Manufacturing Product Portfolio
7.2.5 DPx Recent Developments
7.3 Lonza
7.3.1 Lonza Comapny Information
7.3.2 Lonza Business Overview
7.3.3 Lonza Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.3.4 Lonza Contract Pharmaceutical Manufacturing Product Portfolio
7.3.5 Lonza Recent Developments
7.4 Piramal Healthcare
7.4.1 Piramal Healthcare Comapny Information
7.4.2 Piramal Healthcare Business Overview
7.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio
7.4.5 Piramal Healthcare Recent Developments
7.5 Aenova
7.5.1 Aenova Comapny Information
7.5.2 Aenova Business Overview
7.5.3 Aenova Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.5.4 Aenova Contract Pharmaceutical Manufacturing Product Portfolio
7.5.5 Aenova Recent Developments
7.6 Jubilant
7.6.1 Jubilant Comapny Information
7.6.2 Jubilant Business Overview
7.6.3 Jubilant Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.6.4 Jubilant Contract Pharmaceutical Manufacturing Product Portfolio
7.6.5 Jubilant Recent Developments
7.7 Famar
7.7.1 Famar Comapny Information
7.7.2 Famar Business Overview
7.7.3 Famar Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.7.4 Famar Contract Pharmaceutical Manufacturing Product Portfolio
7.7.5 Famar Recent Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Comapny Information
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio
7.8.5 Boehringer Ingelheim Recent Developments
7.9 Fareva Holding
7.9.1 Fareva Holding Comapny Information
7.9.2 Fareva Holding Business Overview
7.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio
7.9.5 Fareva Holding Recent Developments
7.10 AbbVie
7.10.1 AbbVie Comapny Information
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.10.4 AbbVie Contract Pharmaceutical Manufacturing Product Portfolio
7.10.5 AbbVie Recent Developments
7.11 Nipro Corp
7.11.1 Nipro Corp Comapny Information
7.11.2 Nipro Corp Business Overview
7.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio
7.11.5 Nipro Corp Recent Developments
7.12 Vetter
7.12.1 Vetter Comapny Information
7.12.2 Vetter Business Overview
7.12.3 Vetter Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.12.4 Vetter Contract Pharmaceutical Manufacturing Product Portfolio
7.12.5 Vetter Recent Developments
7.13 Sopharma
7.13.1 Sopharma Comapny Information
7.13.2 Sopharma Business Overview
7.13.3 Sopharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.13.4 Sopharma Contract Pharmaceutical Manufacturing Product Portfolio
7.13.5 Sopharma Recent Developments
7.14 DPT Laboratories
7.14.1 DPT Laboratories Comapny Information
7.14.2 DPT Laboratories Business Overview
7.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio
7.14.5 DPT Laboratories Recent Developments
7.15 Recipharm
7.15.1 Recipharm Comapny Information
7.15.2 Recipharm Business Overview
7.15.3 Recipharm Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.15.4 Recipharm Contract Pharmaceutical Manufacturing Product Portfolio
7.15.5 Recipharm Recent Developments
7.16 NextPharma
7.16.1 NextPharma Comapny Information
7.16.2 NextPharma Business Overview
7.16.3 NextPharma Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.16.4 NextPharma Contract Pharmaceutical Manufacturing Product Portfolio
7.16.5 NextPharma Recent Developments
7.17 Dishman
7.17.1 Dishman Comapny Information
7.17.2 Dishman Business Overview
7.17.3 Dishman Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.17.4 Dishman Contract Pharmaceutical Manufacturing Product Portfolio
7.17.5 Dishman Recent Developments
7.18 Aesica
7.18.1 Aesica Comapny Information
7.18.2 Aesica Business Overview
7.18.3 Aesica Contract Pharmaceutical Manufacturing Revenue and Gross Margin (2019-2024)
7.18.4 Aesica Contract Pharmaceutical Manufacturing Product Portfolio
7.18.5 Aesica Recent Developments
8 North America
8.1 North America Contract Pharmaceutical Manufacturing Revenue (2019-2030)
8.2 North America Contract Pharmaceutical Manufacturing Revenue by Type (2019-2030)
8.2.1 North America Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
8.2.2 North America Contract Pharmaceutical Manufacturing Revenue by Type (2025-2030)
8.3 North America Contract Pharmaceutical Manufacturing Revenue Share by Type (2019-2030)
8.4 North America Contract Pharmaceutical Manufacturing Revenue by Application (2019-2030)
8.4.1 North America Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
8.4.2 North America Contract Pharmaceutical Manufacturing Revenue by Application (2025-2030)
8.5 North America Contract Pharmaceutical Manufacturing Revenue Share by Application (2019-2030)
8.6 North America Contract Pharmaceutical Manufacturing Revenue by Country
8.6.1 North America Contract Pharmaceutical Manufacturing Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Contract Pharmaceutical Manufacturing Revenue by Country (2019-2024)
8.6.3 North America Contract Pharmaceutical Manufacturing Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 Europe
9.1 Europe Contract Pharmaceutical Manufacturing Revenue (2019-2030)
9.2 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2019-2030)
9.2.1 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
9.2.2 Europe Contract Pharmaceutical Manufacturing Revenue by Type (2025-2030)
9.3 Europe Contract Pharmaceutical Manufacturing Revenue Share by Type (2019-2030)
9.4 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2019-2030)
9.4.1 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
9.4.2 Europe Contract Pharmaceutical Manufacturing Revenue by Application (2025-2030)
9.5 Europe Contract Pharmaceutical Manufacturing Revenue Share by Application (2019-2030)
9.6 Europe Contract Pharmaceutical Manufacturing Revenue by Country
9.6.1 Europe Contract Pharmaceutical Manufacturing Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Contract Pharmaceutical Manufacturing Revenue by Country (2019-2024)
9.6.3 Europe Contract Pharmaceutical Manufacturing Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Contract Pharmaceutical Manufacturing Revenue (2019-2030)
10.2 China Contract Pharmaceutical Manufacturing Revenue by Type (2019-2030)
10.2.1 China Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
10.2.2 China Contract Pharmaceutical Manufacturing Revenue by Type (2025-2030)
10.3 China Contract Pharmaceutical Manufacturing Revenue Share by Type (2019-2030)
10.4 China Contract Pharmaceutical Manufacturing Revenue by Application (2019-2030)
10.4.1 China Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
10.4.2 China Contract Pharmaceutical Manufacturing Revenue by Application (2025-2030)
10.5 China Contract Pharmaceutical Manufacturing Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Contract Pharmaceutical Manufacturing Revenue (2019-2030)
11.2 Asia Contract Pharmaceutical Manufacturing Revenue by Type (2019-2030)
11.2.1 Asia Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
11.2.2 Asia Contract Pharmaceutical Manufacturing Revenue by Type (2025-2030)
11.3 Asia Contract Pharmaceutical Manufacturing Revenue Share by Type (2019-2030)
11.4 Asia Contract Pharmaceutical Manufacturing Revenue by Application (2019-2030)
11.4.1 Asia Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
11.4.2 Asia Contract Pharmaceutical Manufacturing Revenue by Application (2025-2030)
11.5 Asia Contract Pharmaceutical Manufacturing Revenue Share by Application (2019-2030)
11.6 Asia Contract Pharmaceutical Manufacturing Revenue by Country
11.6.1 Asia Contract Pharmaceutical Manufacturing Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Contract Pharmaceutical Manufacturing Revenue by Country (2019-2024)
11.6.3 Asia Contract Pharmaceutical Manufacturing Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Contract Pharmaceutical Manufacturing Revenue (2019-2030)
12.2 MEALA Contract Pharmaceutical Manufacturing Revenue by Type (2019-2030)
12.2.1 MEALA Contract Pharmaceutical Manufacturing Revenue by Type (2019-2024)
12.2.2 MEALA Contract Pharmaceutical Manufacturing Revenue by Type (2025-2030)
12.3 MEALA Contract Pharmaceutical Manufacturing Revenue Share by Type (2019-2030)
12.4 MEALA Contract Pharmaceutical Manufacturing Revenue by Application (2019-2030)
12.4.1 MEALA Contract Pharmaceutical Manufacturing Revenue by Application (2019-2024)
12.4.2 MEALA Contract Pharmaceutical Manufacturing Revenue by Application (2025-2030)
12.5 MEALA Contract Pharmaceutical Manufacturing Revenue Share by Application (2019-2030)
12.6 MEALA Contract Pharmaceutical Manufacturing Revenue by Country
12.6.1 MEALA Contract Pharmaceutical Manufacturing Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Contract Pharmaceutical Manufacturing Revenue by Country (2019-2024)
12.6.3 MEALA Contract Pharmaceutical Manufacturing Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings